Anebulo Pharmaceuticals, Inc. (ANEB) Reports In-Line Q4 EPS

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.

You May Also Be Interested In

• Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
• HSBC Upgrades YPF S.A. (YPF) to Buy
• Stripe, Advent In Talks To Buy Paypal - WSJ